Aromataze inhibitors in the treatment of breast cancer

Journal Title: OncoReview - Year 2012, Vol 2, Issue 3

Abstract

The main goal for hormonal therapy of breast cancer is to inhibit action of endogenous estrogens to breast cancer cells. Discovery of hormonal receptors and knowledge of their biological role employment to manner hormonal treatment as target therapy. Postmenopausal estrogens are synthesized from androgens, mainly androstenedione, which is converted into estrone. Aromatase inhibitors potently inhibit aromatase activity and also suppress estrogen levels in plasma and tissue. Aromatase inhibitor are safety and convenient drugs In clinical studies in postmenopausal women with breast cancer shown superior to tamoxifen for the treatment of metastatic disease, and in neoadjuvant approach Studies of adjuvant therapy with aromatase inhibitors include: head-to-head studies of the aromatase inhibitor versus tamoxifen monotherapy, sequential therapy of 2–3 years of tamoxifen followed by an aromatase inhibitor (or the opposite sequence) versus 5 years of tamoxifen monotherapy: extended therapy with an aromatase inhibitor after 5 years of tamoxifen. Aromatase inhibitors are active and are recommended in every stage of breast cancer.

Authors and Affiliations

Tadeusz Pieńkowski

Keywords

Related Articles

Zespół rozpadu guza

Zespół rozpadu guza jest stanem zagrożenia życia występującym u pacjentów z rozległymi nowotworami, u których pod wpływem chemioterapii bądź samoistnie dochodzi do masywnego rozpadu komórek nowotworowych z uwolnieniem ic...

Adriamycin cardiomyopathy with congestive heart failure, cardiogenic shock and emergency heart transplant: 30-year follow up

Doxorubicin chemotherapeutic agent is widely utilized for many types of cancers since the late 1960s. Cardiomyopathy is a well-known side effect of doxorubicin often limiting its use. In many cases doxorubicin cardiomyop...

Selected psychosocial aspects of life of patients with a stoma

Cancer causes huge problems, physical and mental nature mainly. In particular, we cannot forget about the functioning of these patients in the social and spiritual spheres. The increasing trend of incidence of rectal can...

Health and disease – medical and psychological aspects of quality of life in patients with gynecological cancers

Gynecological cancers, due to their location and relation to the aspects of femininity, reproductive ability and body image, are associated not only with the physical dimension of cancer, but also with the mental sphere....

Download PDF file
  • EP ID EP53166
  • DOI -
  • Views 194
  • Downloads 0

How To Cite

Tadeusz Pieńkowski (2012). Aromataze inhibitors in the treatment of breast cancer. OncoReview, 2(3), -. https://europub.co.uk/articles/-A-53166